Ex parte DUTOT - Page 12




          Appeal No. 94-0591                                                           
          Application 07/755,610                                                       
          of essential fatty acids in the lipid phase of Bilton’s emulsions            
          or to increase the long-chain triglyceride content and decrease              
          the medium-chain triglyceride content in the lipid phase of                  
          Babayan’s emulsions.                                                         
               We are at a loss to understand why the combined prior art               
          teachings reasonably would have led persons having ordinary skill            
          in the art to use a lipid emulsion as a parenteral or enteral                
          foodstuff which comprises a lipid phase consisting essentially of            
          long-chain fatty acids in which 15 to 45% by weight of the total             
          fatty acids are essential fatty acids.  It would appear that                 
          absent some reason, incentive, or motivation to reduce the                   
          quantity of high-calorie, essential fatty acids in an enterally              
          or parenterally deliverable foodstuff composition, persons having            
          ordinary skill in the art would have been led by the combined                
          prior art teachings to make and use oil-in-water emulsions                   
          decidedly “rich in” essential fatty acids (Bilton, p. 4, final               
          para.), i.e., oil-in-water emulsions including “substantial                  
          percentages of” essential fatty acids (Wruble, col. 2, l. 17).               
          Thus, we reverse the examiner’s rejection of Claims 1-9, 11, 12              
          and 16-20 under 35 U.S.C. § 103 in view of the combined teachings            
          of Bilton, Wruble and Babayan.                                               
          5.   Other issues                                                            



                                          - 12 -                                       





Page:  Previous  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  Next 

Last modified: November 3, 2007